Zynerba Pharmaceuticals
About
What does Zynerba Pharmaceuticals do?
Zynerba Pharmaceuticals was a specialty pharmaceutical company focused on developing and commercializing novel transdermal cannabinoid therapeutics. Their lead product candidates were designed to treat behavioral and emotional symptoms associated with conditions such as Fragile X syndrome, developmental and epileptic encephalopathies, and peripheral neuropathic pain. The company aimed to leverage the therapeutic potential of cannabinoids through innovative drug delivery systems.
Where is Zynerba Pharmaceuticals headquartered?
Zynerba Pharmaceuticals is headquartered in Wayne, United States.
When was Zynerba Pharmaceuticals founded?
Zynerba Pharmaceuticals was founded in 2007.
What industry does Zynerba Pharmaceuticals operate in?
Zynerba Pharmaceuticals operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Mental Health Tech, Cannabinoid Therapeutics.
What is Zynerba Pharmaceuticals's current status?
Zynerba Pharmaceuticals's current operating status is: Inactive.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.